| 1. | | Recruiting | IMPROVE
Condition: Albuminuria |
| 2. | | Recruiting | Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell |
| 3. | | Recruiting | Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer
Conditions: Melanoma; Kidney Neoplasms; Metastases |
| 4. | | Recruiting | An Investigational Drug in Patients with Type 2 Diabetes Mellitus and Chronic Renal Insufficiency
Conditions: Diabetes Mellitus, Type 2; Chronic Renal Insufficiency |
| 5. | | Recruiting | Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms
Condition: Interstitial Cystitis |
| 6. | | Recruiting | Cinacalcet HCl in Chronic Kidney Disease Subjects with Secondary Hyperparathyroidism Not Receiving Dialysis
Conditions: Kidney Diseases; Chronic Disease |
| 7. | | Recruiting | Treating Systemic Lupus Erythematosus (SLE) Patients with CTLA4-IgG4m (RG2077)
Conditions: Lupus Erythematosus, Systemic; Lupus Nephritis |
| 8. | | Recruiting | Study to Assess Darbepoetin Alfa in Subjects with Chronic Kidney Disease
Conditions: Kidney Disease; Chronic Disease |
| 9. | | Not yet recruiting | Cranberry Juice for Preventing Bacteria in Urine During Pregnancy
Conditions: Urinary Tract Infection; Bacteriuria |
| 10. | | Recruiting | Cellular Adoptive Immunotherapy and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 11. | | Recruiting | Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer |
| 12. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma |
| 13. | | Not yet recruiting | Cranberry Juice for Treatment of Urinary Tract Infections
Condition: Urinary Tract Infections |
| 14. | | Recruiting | Trial to Reduce Cardiovascular Events with Aranesp® Therapy (TREAT)
Conditions: Kidney Diseases; Nephritis; Diabetes Mellitus |
| 15. | | Recruiting | Program to Reduce Incontinence by Diet and Exercise (PRIDE)
Condition: Urinary Incontinence |
| 16. | | Recruiting | Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis
Condition: Kidney Disease |
| 17. | | Recruiting | Treatment of Patients with Metastatic Renal Cell Cancer Using Cultured Tumor-Reactive Lymphocytes and Interleukin-2
Condition: Kidney Neoplasms |
| 18. | | Recruiting | Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis
Condition: Kidney Failure, Chronic |
| 19. | | Recruiting | Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
Conditions: stage III renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma |
| 20. | | Recruiting | Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Kidney Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma |
| 21. | | Recruiting | PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
Condition: Stage IV Renal Cell Cancer |
| 22. | | Recruiting | Behavior Enhances Drug Reduction of Incontinence (BE-DRI)
Condition: Urinary Incontinence |
| 23. | | Recruiting | Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%
Condition: Kidney Failure, Chronic |
| 24. | | Recruiting | Study of LJP 394 in Lupus Patients with History of Renal Disease
Conditions: Lupus Erythematosus, Systemic; Lupus Nephritis |
| 25. | | Not yet recruiting | SU011248 in the Treatment of Patients with Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma
Condition: Renal Cell Carcinoma |
| 26. | | Recruiting | Study of Terlipressin vs. Placebo to Treat Hepatorenal Syndrome Type 1
Condition: Hepatorenal Syndrome |
| 27. | | Not yet recruiting | Optimal Treatment for Kidney Disease in HIV Infected Adults
Conditions: HIV Infections; Kidney Disease |
| 28. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Von Hippel-Lindau Disease and Kidney Cancer
Conditions: stage I renal cell cancer; von Hippel-Lindau Syndrome |
| 29. | | Recruiting | Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
Conditions: transitional cell carcinoma of the bladder; recurrent bladder cancer; stage III bladder cancer; stage IV bladder cancer |
| 30. | | Recruiting | Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer
Conditions: recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer |
| 31. | | Recruiting | Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
Conditions: transitional cell carcinoma of the bladder; stage 0 bladder cancer; stage I bladder cancer |
| 32. | | Recruiting | Genetic Polymorphisms in the RASSF1A Gene in Children With Wilms' Tumor
Conditions: recurrent Wilms' tumor and other childhood kidney tumors; stage I Wilms' tumor; stage II Wilms' tumor; stage III Wilms' tumor; stage IV Wilms' tumor; ... |
| 33. | | Recruiting | 17AAG to Treat Kidney Tumors in von Hippel-Lindau Disease
Conditions: Hippel-Lindau Disease; Kidney Cancer |
| 34. | | Recruiting | RNA-Loaded Dendritic Cell Cancer Vaccine
Condition: Renal Cell Carcinoma |
| 35. | | Recruiting | FR901228 in Treating Patients With Advanced Cancer of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 36. | | Recruiting | Monoclonal Antibody Therapy in Treating Patients With Kidney Cancer
Conditions: renal clear cell carcinoma; stage I renal cell cancer; stage II renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer |
| 37. | | Recruiting | Efficacy and Tolerability of ELMIRON
Condition: Interstitial Cystitis |
| 38. | | Recruiting | Prevention of Vascular Access Graft Failure in Patients with Chronic Renal Failure Requiring Hemodialysis
Conditions: Hyperplasia; Chronic Renal Failure |
| 39. | | Recruiting | Vaccine Therapy Combined With Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer)
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer |
| 40. | | Recruiting | Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder
Conditions: stage 0 bladder cancer; stage I bladder cancer; stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; ... |
| 41. | | Recruiting | Capecitabine Plus GTI-2040 in Treating Patients With Advanced or Metastatic Renal Cell Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 42. | | Not yet recruiting | Interactions Between Cranberry Juice and Antibiotics Used to Treat Urinary Tract Infections
Condition: Urinary Tract Infections |
| 43. | | Recruiting | A Phase II Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer
Condition: Stage IV Renal Cell Cancer |
| 44. | | Recruiting | SU011248 versus Interferon-alfa as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma
Condition: Renal Cell Carcinoma |
| 45. | | Recruiting | Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer |
| 46. | | Recruiting | SU011248 in Treating Patients With Cytokine-Refractory Metastatic Renal Cell Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma |
| 47. | | Recruiting | Short-Term Low-Dose Interferon alfa in Treating Patients With Cancer of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 48. | | Recruiting | Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
Conditions: Bladder Cancer; Urethral Cancer |
| 49. | | Recruiting | Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients with Metastatic Renal Cell Carcinoma
Condition: Renal Cell Carcinoma |
| 50. | | Not yet recruiting | Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL)
Conditions: Atherosclerosis; Cardiovascular Diseases; Hypertension, Renovascular; Renal Artery Obstruction |
